
Study weighs whether aflibercept (Eylea) is cost-effective compared with ranibizumab (Lucentis) in treating diabetic macular edema.

Study weighs whether aflibercept (Eylea) is cost-effective compared with ranibizumab (Lucentis) in treating diabetic macular edema.

The FDA has approved an expanded indication for Tresiba to improve glycemic control in patients with diabetes as young as 1 year.

Active compounds in chili peppers and cannabinoids help calm the gut.

Diabetic patients who received non-invasive shockwave therapy for frozen shoulder had improved range of motion and diminished pain.

Ranibizumab has been prescribed to treat more than 55,000 patients with diabetic macular edema.

Patients in rural areas who have diabetes often have lower access to care and are more likely to be uninsured.

Diabetes is quickly becoming a rural problem in the United States.

Patients in rural areas who have diabetes often have lower access to care and are more likely to be uninsured, hospitalized, or poor.

Plant protein may decrease the risk of type 2 diabetes.

New biomarkers could accurately predict the risk of renal failure among patients with type 1 and type 2 diabetes.

Metformin has been a first-line oral treatment for patients with type 2 diabetes for 20-plus years.

Type 2 diabetes cases increased 8.5% per year among some populations.

Is creating a safe house for drug addicts to freely go and inject heroin really a solution to the drug problem?

High blood pressure can cause insulin resistance, which is associated with an increased diabetes risk.

A recently published report highlights increasing incidence of newly-diagnosed cases of diabetes among children and adolescents.

Patients with diabetes who consumed fruit have a reduced risk of mortality.

Omega-3 supplementation could lead to beta cell regeneration.

Some patient populations with diabetes unable to obtain proper management resources.

Top news of the day from across the health care landscape.

Stevia found to stimulate a channel that regulates insulin secretion.

Top news of the day from across the health care landscape.

Ranibizumab injection (Lucentis) 0.3-mg approved for the treatment of all forms of diabetic retinopathy.

Lucentis is the only drug indicated to treat all forms of diabetic retinopathy.

The Alexa Diabetes Challenge aims to harness Amazon’s Echo device to advance diabetes care.

Oral glucose tolerance and HbA1C tests can better diagnose children with diabetes.